Artificial neural network modeling enhances risk stratification and can reduce downstream testing for patients with suspected acute coronary syndromes, negative cardiac biomarkers, and normal ECGs
Crossref DOI link: https://doi.org/10.1007/s10554-015-0821-9
Published Online: 2015-12-01
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Isma’eel, Hussain A.
Cremer, Paul C.
Khalaf, Shaden
Almedawar, Mohamad M.
Elhajj, Imad H.
Sakr, George E.
Jaber, Wael A.
Text and Data Mining valid from 2015-12-01